Literature DB >> 12819561

Performance of the UA-787 oscillometric blood pressure monitor according to the European Society of Hypertension protocol.

Daniele Longo1, Gianluca Toffanin, Raffaella Garbelotto, Vania Zaetta, Lucio Businaro, Paolo Palatini.   

Abstract

OBJECTIVE: To determine the accuracy of the UA-787 oscillometric blood pressure monitor developed by the A&D Company.
DESIGN: Evaluation of the UA-787 was performed using the new protocol of the European Society of Hypertension. The performance of the monitor was assessed in relation to the subjects' gender, age, skinfold thickness, arm circumference, body mass index and elasticity index of large (C1) and small (C2) arteries.
METHODS: The UA-787 monitor was assessed according to European Society of Hypertension requirements, which are based on four zones of accuracy differing from the mercury standard by 5, 10, 15 mmHg, or more. In all subjects (n=33), indices of large-artery elasticity (C1) and small-artery elasticity (C2) were measured with the HDI/Pulsewave CR-2000 Research Cardiovascular Profiling System.
RESULTS: The UA-787 passed all three phases of the protocol for both systolic and diastolic blood pressure. The mean blood pressure difference between device and the observers was 1.0+/-5.3 mmHg for systolic pressure, and 0.7+/-5.3 mmHg for diastolic pressure. In univariate analysis, the discrepancy between device and the observers was related to forearm circumference (P=0.02) for systolic pressure. For diastolic blood pressure, a significant relationship was found only for heart rate (P<0.01). However, in a multivariable regression analysis no clinical variable was an independent predictor of device-observer discrepancy. In particular, the performance of the UA-787 appeared to be uniform across the whole range of C1 and C2.
CONCLUSIONS: These data show that the A&amp;D UA-787 device satisfies the new recommended European Society of Hypertension accuracy levels for both systolic and diastolic pressure. Its performance is uniform across sub-groups of subjects with different clinical characteristics.

Entities:  

Mesh:

Year:  2003        PMID: 12819561     DOI: 10.1097/00126097-200304000-00006

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  6 in total

1.  Effectiveness of Fixed-Dose Perindopril/Amlodipine on Clinic, Ambulatory and Self-Monitored Blood Pressure and Blood Pressure Variability: An Open-Label, Non Comparative Study in the General Practice.

Authors:  Yuri A Karpov; Vladimir M Gorbunov; Alexander D Deev
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-09-09

2.  Genetic Loci and Novel Discrimination Measures Associated with Blood Pressure Variation in African Americans Living in Tallahassee.

Authors:  Jacklyn Quinlan; Laurel N Pearson; Christopher J Clukay; Miaisha M Mitchell; Qasimah Boston; Clarence C Gravlee; Connie J Mulligan
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

3.  Discrepancy between tonometric ambulatory and cuff-based office blood pressure measurements in patients with type 1 diabetes.

Authors:  Simone Theilade; Maria Lajer; Christel Joergensen; Frederik Persson; Peter Rossing
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-08-03       Impact factor: 3.738

4.  Awareness, treatment, and control of major cardiovascular risk factors in a small-scale Italian community: results of a screening campaign.

Authors:  Stefano Omboni; Giorgia Carabelli; Edoardo Ghirardi; Stefano Carugo
Journal:  Vasc Health Risk Manag       Date:  2013-04-30

5.  Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes.

Authors:  Simone Theilade; Maria Lajer; Frederik Persson; Christel Joergensen; Peter Rossing
Journal:  Diabetes Care       Date:  2012-11-27       Impact factor: 19.112

6.  Rationale, design and respondent characteristics of the 2013-2014 New York City Health and Nutrition Examination Survey (NYC HANES 2013-2014).

Authors:  Lorna E Thorpe; Carolyn Greene; Amy Freeman; Elisabeth Snell; Jesica S Rodriguez-Lopez; Martin Frankel; Amado Punsalang; Claudia Chernov; Elizabeth Lurie; Mark Friedman; Ram Koppaka; Sharon E Perlman
Journal:  Prev Med Rep       Date:  2015-07-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.